TipRanks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
Want to see VRTX full AI Analyst Report?

Compare Vertex Pharmaceuticals (VRTX) vs. Competitors

6,811 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
$547.29
$130.53B
29.81
38.70%
21 Buy
3 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$33.67B
40.41
-45.55%
18 Buy
3 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$12.27B
163.71
14.10%
17 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$2.20B
-13.16
0.71%
4 Buy
8 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.78B
-3.67
-31.53%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.71B
-11.71
-8.76%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRTX
Vertex Pharmaceuticals
522.38
136.64
35.42%
ALNY
Alnylam Pharma
249.59
-196.81
-44.09%
BMRN
BioMarin Pharmaceutical
61.35
7.50
13.93%
SRPT
Sarepta Therapeutics
18.39
0.03
0.16%
NTLA
Intellia Therapeutics
12.16
-4.15
-25.44%
CRSP
Crispr Therapeutics AG
55.70
-5.97
-9.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts